Cointime

Fortress Biotech

company

About

Fortress Biotech is biopharmaceutical company focused on acquiring, developing, and commercializing drugs and drug candidates.

  • 51 - 100

Highlights

Total Funding Amount
$15M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
$15M
Industries
Biotechnology,Health Care,Life Science,Pharmaceutical
Founded date
Jan 1, 2006
Number Of Employee
51 - 100
Operating Status
Active

Fortress Biotech is a biopharmaceutical company focused on acquiring, developing and commercializing high-potential marketed and development-stage drugs and drug candidates. Fortress has 5 marketed products and over 25 programs in development through its majority-owned and majority-controlled partners and at partners it founded and holds significant minority ownership positions. Target therapeutic areas and technologies include oncology, rare diseases, gene and cell therapy, and other areas of high unmet need.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$15M
Fortress Biotech has raised a total of $15M in funding over 2 rounds. Their latest funding was raised on Aug 29, 2012 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 29, 2012 Post-IPO Debt $15M 1 Hercules Capital — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Fortress Biotech is funded by 1 investors. Hercules Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Hercules Capital Yes Post-IPO Debt
Cointime
เนื้อหา
บริษัท